Literature DB >> 26277703

Contrast-enhanced ultrasonographic characteristics of the diseased canine prostate gland.

Alessandro Troisi1, Riccardo Orlandi2, Paolo Bargellini2, Laura Menchetti1, Paulo Borges3, Riccardo Zelli1, Angela Polisca4.   

Abstract

The work was carried out on a total of 26 male dogs that on the basis of clinical examination, prostate ultrasound and prostate biopsy, were divided prospectively into four groups: (1) normal dogs (control group; n = 8); (2) dogs with benign prostatic hyperplasia (group BPH; n = 8); (3) dogs suffering from prostatitis (group prostatitis; n = 4); (4) dogs with prostatic tumors (group tumors; n = 6). The examination of the prostate by means of contrast medium and dedicated ultrasound system allowed a detailed qualitative and quantitative analysis of prostatic vessels in normal and diseased conditions, enabling the detection and characterization of different disease states, and quantification of parameters such as peak intensity of perfusion (%), arrival time of the contrast medium to its maximum value of video intensity (time to peak [TTP; seconds]), regional blood volume, regional blood flow, and mean transit time (MTT [seconds]). The hemodynamic indices TTP (P < 0.01) and MTT (P < 0.001) of diseased prostate groups were significantly lower than those in the normal prostate group although there were no differences among diseases. Optimal cutoff values were 31 seconds (Sensitivity: 72%; Specificity: 88%) and 47 seconds (Sensitivity: 100%; Specificity: 88%) while area under receiver operating characteristic curves were 0.86 (P < 0.01) and 0.97 (P < 0.01) for TTP and MTT, respectively. The qualitative evaluation of vascular patterns showed differences between normal and diseased prostate glands. The latter were characterized by an alteration of the normal vascular appearance consisting of loss of the subcapsular arterioles and lack of a centripetal vascular pattern. The qualitative aspect of the study highlighted the different vascular architecture between BPH, prostatitis, adenocarcinoma, and lymphoma. This study shows how contrast-enhanced ultrasound represents a valid and noninvasive method for highlighting and characterizing prostatic vasculature. Furthermore, it allows the operator to obtain qualitative and quantitative data that are useful for the diagnosis of selected prostatic diseases. In conclusion, contrast-enhanced ultrasound can be a valuable noninvasive diagnostic tool to improve the diagnostic accuracy of prostate diseases in the dog.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast-enhanced ultrasound; Dog; Prostate; Vascularization

Mesh:

Substances:

Year:  2015        PMID: 26277703     DOI: 10.1016/j.theriogenology.2015.07.029

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  5 in total

1.  Ultrasonographic measurements of the prostate gland in castrated adult dogs.

Authors:  Femke Bosma; Saffiera Wijsman; Simone Huygens; Maartje Passon-Vastenburg
Journal:  Acta Vet Scand       Date:  2022-07-08       Impact factor: 2.048

2.  The Value of Contrast-Enhanced Ultrasound in the Diagnosis of Cesarean Scar Pregnancy.

Authors:  Xi Xiong; Ping Yan; Chunyan Gao; Qiulei Sun; Fenglian Xu
Journal:  Biomed Res Int       Date:  2016-05-31       Impact factor: 3.411

3.  Plasmid DNA vaccine coding eight repeats of gonadotrophin-releasing hormone induced atrophy of prostate in male mice.

Authors:  Umme K Rima; Abu S M Bari; Mohammad Z Hossain; Mohammad A H Khan
Journal:  Prostate Int       Date:  2018-01-12

Review 4.  Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?

Authors:  Magdalena Schrank; Stefano Romagnoli
Journal:  Animals (Basel)       Date:  2020-01-05       Impact factor: 2.752

5.  Characterization of Testicular Tumor Lesions in Dogs by Different Ultrasound Techniques.

Authors:  Riccardo Orlandi; Emanuela Vallesi; Cristiano Boiti; Angela Polisca; Paolo Bargellini; Alessandro Troisi
Journal:  Animals (Basel)       Date:  2022-01-17       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.